UnitedHealth Group, Morgan Stanley rise; PNC Financial, Live Nation fall, Tuesday, 4/16/2024
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Tuesday:
Intra-Cellular Therapies Inc., up $15.08 to $79.84.
The biopharmaceutical company made an encouraging update on its potential treatment for a depressive disorder.
UnitedHealth Group Inc., up $23.26 to $468.89.
The health insurance giant beat Wall Street’s first-quarter earnings and revenue forecasts.
Morgan Stanley, up $2.15 to $89.14.
The investment bank’s first-quarter earnings and revenue beat analysts’ forecasts.
Live Nation Entertainment Inc., down $7.56 to $92.21.
The U.S. Justice Department is reportedly preparing an antitrust lawsuit against the ticket seller and concert promoter.
Barrick Gold Corp., down 89 cents to $16.48.
Investors were disappointed by the gold and copper miner’s first-quarter production.
PNC Financial Services Group Inc., down $3.02 to $146.54.
Related articles
UN Chinese Language Day celebrated in Tunisia
Students learn inscription rubbing in the Confucius Institute at Carthage University in Tunis, Tunis2024-04-30Blinken will visit the Mideast again this week. What can he achieve?
WASHINGTON (AP) — Secretary of State Antony Blinken is returning to the Middle East on his seventh d2024-04-30Anthony Edwards scores 36 points, Timberwolves beat Suns 126
PHOENIX (AP) — Anthony Edwards hit a jumper late in the fourth quarter and snarled as he ran down th2024-04-30Josh Naylor, Ramon Laureano help Guardians outlast Braves 4
ATLANTA (AP) — Josh Naylor and Ramon Laureano had RBIs in the 11th inning and the Cleveland Guardian2024-04-30Democratic mayor joins Kentucky GOP lawmakers to celebrate state funding for Louisville
The amount of state funding headed to Kentucky’s largest city to support downtown renewal, education2024-04-30Shedeur Sanders shines, new transfers step up in Colorado's spring game on rainy and cool day
BOULDER, Colo. (AP) — The rain and the cold couldn’t dampen the demeanor of Deion Sanders. The cowbo2024-04-30
atest comment